STOCK TITAN

The Magnum Ice Cream Company N.V. 424B Filings

MICC NYSE

Every 424B that The Magnum Ice Cream Company N.V. (MICC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow MICC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MICC filings page.

Rhea-AI Summary

The Magnum Ice Cream Company N.V. has filed a prospectus supplement covering the potential resale by selling shareholders of up to 121,604,413 ordinary shares. Ordinary shares trade in Amsterdam, London and New York, with 612,259,739 shares outstanding and a NYSE price of $18.24 on 29 July 2026.

For H1 2026, revenue was €4.691 billion versus €4.503 billion, with 4.7% Organic Sales Growth driven by 2.5% volume and 2.2% price. Adjusted EBIT rose to €716 million (margin 15.3%), while net profit declined to €349 million, mainly due to higher finance costs, hyperinflation effects in Türkiye and higher taxes. Free cash flow increased to €273 million, and net debt reached €3.264 billion.

The company completed ice cream acquisitions in India and Portugal, contributing to growth and raising goodwill. A productivity programme delivered €90 million of savings in H1 toward a medium-term €500 million goal. The Turkish Competition Authority opened an investigation into freezer-cabinet practices and imposed an interim measure on cabinet capacity allocation. Management reaffirms 2026 guidance for 3–5% Organic Sales Growth and an Adjusted EBITDA margin improvement of 40–60 basis points on a comparable perimeter.

Rhea-AI Summary

The Magnum Ice Cream Company N.V. registers up to 121,604,413 ordinary shares for resale by selling shareholders under a Prospectus Supplement dated June 8, 2026.

The supplement incorporates by reference a Form 6-K reporting AGM results: shareholders approved all resolutions on a poll, including adoption of the financial statements and board reappointments, and approved the Foundation Plan for Growth with 77.37% support. The company reported 612,259,739 ordinary shares outstanding as of June 5, 2026 and a last reported NYSE sale price of $17.07 per share.

Rhea-AI Summary

The Magnum Ice Cream Company N.V. files a Prospectus Supplement to its Form F-1 registering up to 121,604,413 ordinary shares for resale by selling shareholders. The Supplement incorporates a Q1 2026 trading update reporting Group revenue of €1.770bn, organic sales growth 4.5%, and reaffirmed full‑year guidance of OSG 3–5% with Adjusted EBITDA margin improvement of 40–60bps on a comparable perimeter basis. The Company had 612,259,739 ordinary shares outstanding as of April 29, 2026 and the last reported NYSE sale price was $13.06 per share.

Rhea-AI Summary

The Magnum Ice Cream Company N.V. is registering for resale up to 121,604,413 ordinary shares. These shares are being registered for resale by the selling securityholders pursuant to the Registration Rights Agreement dated October 1, 2025; the Company will receive no proceeds from these resales.

The prospectus states the 121,604,413 shares equal approximately 19.86% of the 612,259,739 Ordinary Shares outstanding as of March 30, 2026. The Selling Securityholders may sell from time to time through public or private transactions, at prevailing market prices or negotiated prices, under a variety of distribution methods described in the plan of distribution.